These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 6843688)
21. Effect of 1,3-di-n-butyl-7-(2-oxopropyl)-xanthine (denbufylline) on metabolism and function of cerebral cholinergic neurons. Katsura M; Hashimoto T; Kuriyama K Jpn J Pharmacol; 1991 Feb; 55(2):233-40. PubMed ID: 1648639 [TBL] [Abstract][Full Text] [Related]
22. Mapping of the distribution of high affinity choline uptake and choline acetyltransferase in the striatum. Takano Y; Kohjimoto Y; Uchimura K; Kamiya H Brain Res; 1980 Aug; 194(2):583-7. PubMed ID: 7388635 [No Abstract] [Full Text] [Related]
23. Role of high-affinity choline uptake on extracellular choline and acetylcholine evoked by NMDA. Zapata A; Capdevila JL; Trullas R Synapse; 2000 Mar; 35(4):272-80. PubMed ID: 10657037 [TBL] [Abstract][Full Text] [Related]
24. The effect of neuroleptics on acetylcholine concentration and choline uptake in striatum: Implications for regulation of acetylcholine metabolism. Sherman KA; Hanin I; Zigmond MJ J Pharmacol Exp Ther; 1978 Sep; 206(3):677-86. PubMed ID: 29960 [TBL] [Abstract][Full Text] [Related]
25. Increase in striatal acetylcholine by picrotoxin in the rat: evidence for a gabergic-dopaminergic-cholinergic link. Ladinsky H; Consolo S; Bianchi S; Jori A Brain Res; 1976 May; 108(2):351-61. PubMed ID: 945112 [TBL] [Abstract][Full Text] [Related]
26. Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway. Murrin LC; Roth RH Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):15-20. PubMed ID: 12482 [TBL] [Abstract][Full Text] [Related]
27. Alteration of metabolism of acetylcholine induced by 2-deoxy-D-glucose in the gastroduodenum of the rat. Muramatsu M; Chaki S; Arai I; Aihara H Neuropharmacology; 1990 Jan; 29(1):47-54. PubMed ID: 2304615 [TBL] [Abstract][Full Text] [Related]
28. The cholinergic system and memory: amelioration of ethanol-induced memory deficiency by physostigmine in rat. Arendt T; Schugens MM; Bigl V Acta Neurobiol Exp (Wars); 1990; 50(4-5):251-61. PubMed ID: 2130647 [TBL] [Abstract][Full Text] [Related]
29. Postnatal development of the acetylcholine system in different parts of the rat cerebellum. Kása P; Bánsághy K; Rakonczay Z; Gulya K J Neurochem; 1982 Dec; 39(6):1726-32. PubMed ID: 7142998 [TBL] [Abstract][Full Text] [Related]
30. Veratridine-induced breakdown of cytosolic acetylcholine in rat hippocampal minces: an intraterminal form of acetylcholinesterase or choline O-acetyltransferase? Carroll PT; Badamchian M; Craig P; Lyness WH Brain Res; 1986 Sep; 383(1-2):83-99. PubMed ID: 3768708 [TBL] [Abstract][Full Text] [Related]
31. D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum. Consolo S; Wu CF; Fusi R J Pharmacol Exp Ther; 1987 Jul; 242(1):300-5. PubMed ID: 2886638 [TBL] [Abstract][Full Text] [Related]
32. Arachidonic acid inhibits choline uptake and depletes acetylcholine content in rat cerebral cortical synaptosomes. Boksa P; Mykita S; Collier B J Neurochem; 1988 Apr; 50(4):1309-18. PubMed ID: 3126267 [TBL] [Abstract][Full Text] [Related]
33. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y. Robertson GS; Staines WA Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982 [TBL] [Abstract][Full Text] [Related]
34. Effect of acute and chronic treatment with dichlorvos on rat brain cholinergic parameters. Teichert K; Szymczyk T; Consolo S; Ladinsky H Toxicol Appl Pharmacol; 1976 Jan; 35(1):77-81. PubMed ID: 1258061 [No Abstract] [Full Text] [Related]
35. Inhibition of high-affinity choline uptake in the rat hippocampus by in vivo injection of phenobarbital in the medial septum. Richter JA; Gormley JM J Pharmacol Exp Ther; 1986 May; 237(2):563-8. PubMed ID: 3009793 [TBL] [Abstract][Full Text] [Related]
36. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions. Mouton PR; Meyer EM; Dunn AJ; Millard W; Arendash GW Brain Res; 1988 Mar; 444(1):104-18. PubMed ID: 3359282 [TBL] [Abstract][Full Text] [Related]
37. Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382. van Nieuwenhuijzen PS; McGregor IS; Chebib M; Hunt GE Neuroscience; 2014 Sep; 277():700-15. PubMed ID: 25088910 [TBL] [Abstract][Full Text] [Related]
38. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus. Rossner S; Schliebs R; Härtig W; Bigl V Brain Res Bull; 1995; 38(4):371-81. PubMed ID: 8535860 [TBL] [Abstract][Full Text] [Related]
39. Presynaptic cholinergic mechanisms in brain of aged rats with memory impairments. Sherman KA; Kuster JE; Dean RL; Bartus RT; Friedman E Neurobiol Aging; 1981; 2(2):99-104. PubMed ID: 7197758 [TBL] [Abstract][Full Text] [Related]
40. Increase in exogenous choline fails to elevate the content or turnover rate of cortical, striatal, or hippocampal acetylcholine. Brunello N; Cheney DL; Costa E J Neurochem; 1982 Apr; 38(4):1160-3. PubMed ID: 7062035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]